Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $24.02 million. The enterprise value is $22.77 million.

Market Cap	24.02M
Enterprise Value	22.77M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

AKTX has 24.76 million shares outstanding. The number of shares has increased by 76.18% in one year.

Current Share Class	n/a
Shares Outstanding	24.76M
Shares Change (YoY)	+76.18%
Shares Change (QoQ)	+29.46%
Owned by Insiders (%)	50.57%
Owned by Institutions (%)	1.33%
Float	11.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-3.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio	0.29
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-145.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	260.56%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.41% in the last 52 weeks. The beta is 0.79, so AKTX's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-59.41%
50-Day Moving Average	1.14
200-Day Moving Average	2.34
Relative Strength Index (RSI)	39.07
Average Volume (20 Days)	30,867

Short Selling Information

Short Interest	126,747
Short Previous Month	127,361
Short % of Shares Out	0.23%
Short % of Float	n/a
Short Ratio (days to cover)	1.92

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.44M
Pretax Income	n/a
Net Income	-20.16M
EBITDA	-17.43M
EBIT	-17.44M
Earnings Per Share (EPS)	-$2.46

Balance Sheet

The company has $2.25 million in cash and $1.00 million in debt, giving a net cash position of $1.25 million or $0.05 per share.

Cash & Cash Equivalents	2.25M
Total Debt	1.00M
Net Cash	1.25M
Net Cash Per Share	$0.05
Equity (Book Value)	-6.69M
Book Value Per Share	-0.55
Working Capital	-6.69M

Cash Flow

Operating Cash Flow	-14.84M
Capital Expenditures	n/a
Free Cash Flow	-14.84M
FCF Per Share	-$0.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-76.18%
Shareholder Yield	-76.18%
Earnings Yield	-83.93%
FCF Yield	-61.78%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Aug 17, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1